This company is no longer active
Selectimmune Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Selectimmune Pharma has a total shareholder equity of SEK6.1M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK7.1M and SEK1.0M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr5.84m |
Equity | kr6.10m |
Total liabilities | kr1.03m |
Total assets | kr7.13m |
Financial Position Analysis
Short Term Liabilities: SELECT B's short term assets (SEK6.3M) exceed its short term liabilities (SEK1.0M).
Long Term Liabilities: SELECT B's short term assets (SEK6.3M) do not cover its long term liabilities (SEK-1.0).
Debt to Equity History and Analysis
Debt Level: SELECT B is debt free.
Reducing Debt: SELECT B has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SELECT B has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SELECT B has less than a year of cash runway if free cash flow continues to reduce at historical rates of 24.5% each year